Stock Analysis

Results: Nucor Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

NYSE:NUE
Source: Shutterstock

As you might know, Nucor Corporation (NYSE:NUE) just kicked off its latest quarterly results with some very strong numbers. Results were good overall, with revenues beating analyst predictions by 7.4% to hit US$8.1b. Statutory earnings per share (EPS) came in at US$2.68, some 9.2% above whatthe analysts had expected. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

View our latest analysis for Nucor

earnings-and-revenue-growth
NYSE:NUE Earnings and Revenue Growth July 26th 2024

Following the recent earnings report, the consensus from eleven analysts covering Nucor is for revenues of US$30.8b in 2024. This implies a measurable 5.7% decline in revenue compared to the last 12 months. Statutory earnings per share are expected to plunge 29% to US$10.04 in the same period. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$30.5b and earnings per share (EPS) of US$10.67 in 2024. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a minor downgrade to their earnings per share forecasts.

The consensus price target held steady at US$186, with the analysts seemingly voting that their lower forecast earnings are not expected to lead to a lower stock price in the foreseeable future. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. The most optimistic Nucor analyst has a price target of US$240 per share, while the most pessimistic values it at US$170. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Nucor shareholders.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 11% by the end of 2024. This indicates a significant reduction from annual growth of 13% over the last five years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 5.2% per year. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - Nucor is expected to lag the wider industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Nucor's revenue is expected to perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for Nucor going out to 2026, and you can see them free on our platform here.

You can also see whether Nucor is carrying too much debt, and whether its balance sheet is healthy, for free on our platform here.

Valuation is complex, but we're here to simplify it.

Discover if Nucor might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.